Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nils Confer
Observed names:
N. Confer,
Nils F. Confer,
Nils F. Confer
Institution:
Aquestive (United States)
Observed institutions:
University of North Texas Health Science Center,
Poplar Forest,
CARE Fertility,
Aquestive (United States),
Colorado Center for Reproductive Medicine,
The University of Texas Southwestern Medical Center
show all 6
ORCID:
0000-0002-7904-1387
Observed ORCID:
0000-0002-7904-1387
OpenAlex ID:
A5024723847
Introduction of blastocyst culture and transfer for all patients in an in vitro fertilization program
1999
·
Del Marek
, Martin Langley
, et al.
·
Fertility and Sterility
·
202
PDF
Molybdenum cofactor deficiency: A natural history
2022
·
Ronen Spiegel
, Bernd C. Schwahn
, et al.
·
Journal of Inherited Metabolic Disease
·
56
PDF
A Phase 1 Pharmacokinetic Study of Cysteamine Bitartrate Delayed-Release Capsules Following Oral Administration with Orange Juice, Water, or Omeprazole in Cystinosis
2018
·
Danielle Armas
, Robert J. Holt
, et al.
·
Advances in Therapy
·
13
PDF
Multiple PolK (POLK) transcripts in mammalian testis
2004
·
Caixia Guo
, Tianshu Gao
, et al.
·
DNA repair
·
10
Biochemical Association of Poly(ADP‐ribose) Polymerase‐1 and Its Apoptotic Peptide Fragments with DNA Polymerase β
2004
·
Nils F. Confer
, Sunitha R. Kumari
, et al.
·
Chemistry & Biodiversity
·
10
Sp026quantification of Dimethylsulfide Associated With Cysteamine Bitartate-induced Halitosis Using Breath Analysis in Cystinosis Patients Treated With Delayed-release and Immediate-release Cysteamine Bitartrate
2017
·
Larry Greenbaum
, Georges Deschênes
, et al.
·
Nephrology Dialysis Transplantation
·
3
PDF
Pharmacokinetics and pharmacodynamics of AQST-109
2025
·
David Golden
, Matthew Greenhawt
, et al.
·
Annals of Allergy Asthma & Immunology
·
2
Late-Onset Molybdenum Cofactor Deficiency Type A: A Treatable Cause of Developmental Delay
2024
·
Allan M. Lund
, Siren Berland
, et al.
·
PEDIATRICS
·
1
PDF
Epinephrine Plasma Concentration and Hemodynamic Threshold Response Following Novel Sublingual Epinephrine Administration
2026
·
Nils Confer
, Matthew Greenhawt
, et al.
·
Journal of Allergy and Clinical Immunology
Novel Sublingual Epinephrine Is Not Associated with a Diastolic Blood Pressure Dip
2026
·
Nils Confer
, Carl Kraus
, et al.
·
Journal of Allergy and Clinical Immunology
Sublingual Epinephrine Provides Consistent Pharmacokinetics in Both Adult and Pediatric Subjects
2025
·
N. Confer
, D. Golden
, et al.
·
Annals of Allergy Asthma & Immunology
Phase 1 Evaluation of Sublingual Film: Pharmacokinetics/pharmacodynamics, Safety, Tolerability in at Risk Pediatric Patients
2025
·
C. Kraus
, A. Anagnostou
, et al.
·
Annals of Allergy Asthma & Immunology
Recognizing Unmet Needs in Anaphylaxis Care: Insights From Clinician and Caregiver Surveys
2025
·
N. Confer
, C. Kraus
·
Annals of Allergy Asthma & Immunology
Durability of AnaphylmTM (Epinephrine Sublingual Film) under Real-World Use
2025
·
Stephen Wargacki
, Vincent Buono
, et al.
·
Journal of Allergy and Clinical Immunology
A novel imaging technology to improve subcutaneous nodule quantification in Farber disease
2023
·
Nils F. Confer
, Kathleen Crosby
, et al.
·
Molecular Genetics and Metabolism
Increased survival in MoCD type A patients treated with cPMP when compared to a natural history cohort
2021
·
Nils Confer
, Donald Basel
, et al.
·
Molecular Genetics and Metabolism
ENZYMATIC OLIGOMERIZATION OF PARP‐1 WITH ITSELF, DNA POLYMERASE β AND P53
2006
·
Rafael Alvarez‐Gonzalez
, Nils F. Confer
, et al.
·
The FASEB Journal
Does he not see the wind
1996
·
Nils Confer
·
Digital Commons @ Butler University (Butler University)
PDF
Show more works
View as search
Works count:
18
Citation count:
297
H-index:
5
I10-index:
5
Year
Topic
Type